Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans
Clinical trial NCT00393445 · COMPLETED
Trial details
- NCT number
- NCT00393445
- Sponsor
- Ludwig-Maximilians - University of Munich
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.